LASMED LTD LIABILITY CORP
Medtech · Private
Non-invasive diagnostic instrument using selective laser stimulation to measure function of small-diameter nerve fiber subtypes in skin for CIPN assessment
- Grants
- $300K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $70K
- 4 awards · Health and Human S
- #550 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ct;;igf Lasmed Limited Liability COMPANY:1187527 [15-011326] | $4,280 | |
| Federal grant | Department of Health and Human Services · Phase I · Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN | $300,000 | |
| Federal contract | Department of Health and Human Services · Infrared Diode Laser With An Output Wavelength Of 980 Nm, With Variable Power Control With A Minimum Output Of 0.2 W And Maximum Power Output Of 20 W, Pulse Switching Time Of 10-50 Ms, Has Tti Control, Light Delivered Through A 0.22 Mm Optical Fiber For A Spot Diameter Of 1 Or 5 Mm, Red Light Guiding Light, And Have 2-POINT Safety Override | $35,760 | |
| Federal contract | Department of Health and Human Services · Lasmed Limited Liability COMPANY:1187527 [18-016930] | $14,000 | |
| Federal contract | Department of Health and Human Services · Lasmed Limited Liability COMPANY:1187527 [22-012580] | $15,959 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 547 | LUMO IMAGING LLC | $74K | — |
| 548 | RHEONIX, INC. | $73K | $45M |
| 549 | BIODESIX INC | $70K | $156M |
| 550 | LASMED LTD LIABILITY CORP | $70K | — |
| 551 | Focus Ventures, Inc. | $69K | — |
| 552 | EmergenceMed, LLC | $69K | — |
| 553 | PRECISION VISION, INC. | $68K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.